European Journal of Pharmaceutics and Biopharmaceutics

The European Journal of Pharmaceutics and Biopharmaceutics is a pharmaceutics journal published by Elsevier on behalf of the International Association for Pharmaceutical Technology, founded in 1991 as the successor to Acta Pharmaceutica Technologica, with a 2025 impact factor of 5.0（European Journal of Pharmaceutics and Biopharmaceutics）是由（Elsevier）代表国际制药技术协会（APV）出版的制药学期刊，1991 年作为（Acta Pharmaceutica Technologica）的承接刊创办，2025 年影响因子为 5.0。

Scope

• The journal publishes novel, hypothesis-driven research in pharmaceutics and biopharmaceutics该刊发表制药学与生物制药学领域新颖、以假说驱动的研究。
• It covers the design of drug delivery systems for small molecules, proteins and nucleic acids内容涵盖小分子、蛋白与核酸的药物递送系统设计。
• Manufacturing process design and the biomedical aspects of drug product design are within scope生产工艺设计以及药物产品设计的生物医学层面均在收稿范围。
• Controlled release strategies across biological barriers and the physicochemical aspects of product development are included跨越生物屏障的控释策略与产品开发的物理化学层面亦被涵盖。
• Work on new excipients also falls within the journal's remit新型辅料的研究也属于该刊的范畴。

History

• It was founded in 1991, continuing the APV journal Acta Pharmaceutica Technologica, which ran from 1979 to 1990该刊 1991 年创办，承接 1979 至 1990 年由（APV）出版的（Acta Pharmaceutica Technologica）。
• Its early volumes were published in Stuttgart by Wissenschaftliche Verlagsgesellschaft before the journal moved to Elsevier Science in Amsterdam其早期卷次由（Stuttgart）的（Wissenschaftliche Verlagsgesellschaft）出版，后转由（Amsterdam）的（Elsevier Science）出版。
• It is the official journal of the International Association for Pharmaceutical Technology该刊是国际制药技术协会的官方期刊。
• It is issued nine times a year and had a 2025 impact factor of 5.0该刊每年出版九期，2025 年影响因子为 5.0。

Editors

• Thomas Rades of the University of Copenhagen has been editor-in-chief since 2022现任主编为（University of Copenhagen）的 Thomas Rades，自 2022 年起任职。
• The journal operates a hybrid open access model, allowing authors to make articles freely available on payment该刊采用混合开放获取模式，作者付费即可让文章免费开放。
• Manuscripts span formulation science, drug delivery and pharmaceutical manufacturing稿件涵盖制剂科学、药物递送与制药工程。
• Submissions undergo peer review before acceptance稿件须经同行评审后方可录用。